Patents by Inventor Yeomoon SIM

Yeomoon SIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES
    Publication number: 20250276041
    Abstract: The present invention relates to a composition for preventing or treating neurodegenerative diseases. The pharmaceutical composition of the present invention contains at least two selected from the group consisting of an interleukin 10 (IL-10) protein or a gene encoding the same, a glial cell line-derived neurotrophic factor (GDNF) protein or a gene encoding the same, and a glutamate decarboxylase (GAD) protein or a gene encoding the same. Since the pharmaceutical composition of the present invention exhibits a better effect of alleviating and preventing neurodegenerative diseases by co-administration of active ingredients than upon single administration, the pharmaceutical composition of the present invention can exhibit the same or higher effect only with a low concentration of the active ingredients. Therefore, the pharmaceutical composition of the present invention can be advantageously used for the prevention or treatment of neurodegenerative diseases.
    Type: Application
    Filed: March 11, 2022
    Publication date: September 4, 2025
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Jangjoon PARK, Jaeil SHIN, Soonoh HONG, Kyungran KIM, Minju KIM, Hyelin JI, Yeomoon SIM, Haeun KIM, Juyoun LEE, Hyejin LEE
  • Method for delivery of biological molecule to nervous tissue
    Patent number: 10898590
    Abstract: A method for delivery of a therapeutic agent to a nervous tissue. In particular, a method of delivering a therapeutic agent to a nervous tissue protected by the brain-blood barrier or meninges is disclosed. The method for delivery allows delivery of a therapeutic agent to a nervous tissue with high efficiency. In addition, the delivery method of a therapeutic agent to a nervous tissue is safe since it has lower side effects such as nervous damage than a method of administering a therapeutic agent directly to a nervous tissue.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: January 26, 2021
    Assignee: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong Kim, Heonsik Choi, Kyoungbaek Choi, Minjung Kim, Yejin Kwon, Hyeonyoul Lee, Minju Kim, Daewook Kim, Jangjoon Park, Yeomoon Sim
  • COMPOSITION FOR ALLEVIATING OR TREATING PAIN
    Publication number: 20190255152
    Abstract: The present invention relates to a composition for alleviating or treating pain. A pharmaceutical composition of the present invention contains two or more selected from the group consisting of GAD, IL-10, and a gene encoding GDNF. The pharmaceutical composition of the present invention exhibits an excellent analgesic effect at a dosage lower than that of individual administration since genes are coadministered, and thus conventional side effects and toxicity can be reduced. Therefore, the pharmaceutical composition of the present invention can be useful in alleviating or treating pain.
    Type: Application
    Filed: October 31, 2017
    Publication date: August 22, 2019
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong KIM, Heonsik CHOI, Yejin KWON, Minjung KIM, Minju KIM, Daewook KIM, Jangjoon PARK, Jongho CHO, Soondong LEE, Joonsung KIM, Yeomoon SIM
  • METHOD FOR DELIVERY OF BIOLOGICAL MOLECULE TO NERVOUS TISSUE
    Publication number: 20190099504
    Abstract: A method for delivery of a therapeutic agent to a nervous tissue. In particular, a method of delivering a therapeutic agent to a nervous tissue protected by the brain-blood barrier or meninges is disclosed. The method for delivery allows delivery of a therapeutic agent to a nervous tissue with high efficiency. In addition, the delivery method of a therapeutic agent to a nervous tissue is safe since it has lower side effects such as nervous damage than a method of administering a therapeutic agent directly to a nervous tissue.
    Type: Application
    Filed: December 12, 2018
    Publication date: April 4, 2019
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong KIM, Heonsik CHOI, Kyoungbaek CHOI, Minjung KIM, Yejin KWON, Hyeonyoul LEE, Minju KIM, Daewook KIM, Jangjoon PARK, Yeomoon SIM